Stakeholder Assessment of Implementing the Commission on Cancer Operative Standards for Cancer Surgery

NCT05583981 | Completed

• 4 other identifiers: OSU-21198NCI-2021-087251K08CA263488-01A1202010121
• Study Type: observational
• Target: 31
• Locations: 1 country
• Sites: 1

Brief Summary

This study investigates the barriers to implementing breast Synoptic Operative Reports. Information from this study may help researchers identify performance objectives for the breast Synoptic Operative Reports to be adopted, implemented and continued.

Conditions

Breast Carcinoma

Outcome Measures

Primary Outcomes (2)

• Barriers to implementing breast Synoptic Operative Reports

  This is a qualitative study in which we will conduct in-depth, semi-structured interviews with key stakeholders. A template analysis identifying priori themes will be used, then coding for impact and/or implementation strategy.

  Up to 2 years

• Performance objectives for the breast Synoptic Operative Reports to be adopted, implemented, and continued

  This is a qualitative study in which we will conduct in-depth, semi-structured interviews with key stakeholders.A template analysis identifying priori themes will be used, then coding for impact and/or implementation strategy.

  Up to 2 years

Study Arms (1)

Observational (interview)

Participants participate in interview over 30-60 minutes.

Other: Interview

Interventions

Interview OTHER

Participate in interview

Observational (interview)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Key stakeholders (e.g. electronic medical record \[EMR\] engineer, Cancer Liaison Physician \[CLP\], breast surgeon, and cancer registrar administrator) from Ohio State University and 3 other Commission on Cancer (CoC)-accredited cancer programs

You may qualify if:

• Adults \>= 18 years
• Available phone or device for contact
• English speaking
• Works at Commission on Cancer (CoC) - accredited cancer program

Sponsors & Collaborators

• Ohio State University Comprehensive Cancer Center: lead
• National Cancer Institute (NCI): collaborator

Study Sites (1)

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, 43210, United States

Location

Related Links

• The Jamesline

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Interviews as Topic

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Ko Un Park, MD

  Ohio State University Comprehensive Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: October 12, 2022
• First Posted: October 18, 2022
• Study Start: December 1, 2021
• Primary Completion: June 15, 2022
• Study Completion: June 15, 2022
• Last Updated: March 2, 2023

Record last verified: 2023-02

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)